Please login to the form below
ICS
This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.
FDA grants priority review for AZ, Amgen’s tezepelumab for asthma
In this trial, SoC was defined as medium- or high-dose inhaled corticosteroids (ICS) plus at least one additional controller medication, with or without oral corticosteroids (OCS).
Latest news
-
AZ, Amgen file first-in-class asthma drug with the FDA
In this trial, SoC was defined as medium- or high-dose inhaled corticosteroids (ICS) plus at least one additional controller medication, with or without oral corticosteroids (OCS).
-
Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
An exploratory analysis showed that among these patients, the intracranial objective response rate (IC-ORR) was 82% in the Lorbrena arm compared to 23% in the Xalkori arm.
-
AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient population
In this trial, SoC was defined as medium- or high-dose inhaled corticosteroids (ICS) plus at least one additional controller medication, with or without oral corticosteroids (OCS).
-
AZ, Amgen’s investigational asthma drug comes good in phase 3
The phase 3 NAVIGATOR trial evaluated tezepelumab plus standard of care, which included medium- or high-dose inhaled corticosteroids (ICS) plus at least one controller medication, with or without oral corticosteroids
-
Novartis reveals full phase 3 results for Enerzair Breezhaler
and a high dose of an inhaled corticosteroid (ICS), who had experienced one or more asthma exacerbations in the previous year. ... symptoms despite receiving a LABA/ICS, which is the standard of care,” said Huib Kerstjens, head of the Department of
AZ, Amgen file first-in-class asthma drug with the FDA
Pfizer’s ALK inhibitor Lorbrena scores expanded FDA approval for first-line NSCLC
AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient population
Novartis reveals full phase 3 results for Enerzair Breezhaler
More from news
Approximately 1 fully matching, plus 34 partially matching documents found.
Latest Intelligence
-
GSK forges ahead with its dynamic COPD and asthma portfolio
For instance, in the UK, US, Canada and Spain, the first treatment was an ICS/LABA, such Seretide or Symbicort, while in Germany it was a bronchodilator.
-
The roaring ‘20s and Generation Z
For instance, the draft NHS Standard Contract 2020/21, published in December 2019 will see NHS Trusts and CCGs being contractually obliged to work collectively as a single local ICS system, ... Over the next five years at least, campaigns and messaging
-
NHS regional footprints
CCGs in action. In Nottinghamshire, six CCGs have joined forces to lead the strategic development of integrated care within the geographical area originally allocated to the Nottinghamshire ICS.
-
Deal Watch table for August 2014
600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).
GSK forges ahead with its dynamic COPD and asthma portfolio
The roaring ‘20s and Generation Z
NHS regional footprints
Deal Watch table for August 2014
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Understanding the role of provider collaboratives
Meanwhile, trusts that operate across a large area or are within a small Integrated Care System (ICS) are likely to want to be part of a collaborative that spans “multiple systems”. ... For example, two or three CCGs that currently have separate APCs
-
How does the government plan to reshape the NHS?
Alternatively, CCGs may merge to become ICS-sized structures. These changes are likely to affect Area Prescribing Committees (APCs). ... For example, if two or three CCGs that currently have separate APCs merge to fit the size of an ICS, or are absorbed
-
Integrated NHS finances: what do they mean for High Cost Drugs?
The money will be used by the ICS to strategically commission services at a place- based level. ... However, as CCGs merge into ICS boundaries, a lot of the specialised commissioning budget will move to the single pot managed by the ICS.
-
Delivering true value: what does it mean for KAM in cancer care?
The real challenge of working with these new ICS accounts and other integrated care organisations is very much about teamwork.
-
How will the Tories’ historic win shape the NHS?
Integrated care. The Tories’ win has provided assurance that there will be 100 percent Integrated Care System (ICS) coverage across England by April 2021, as promised in the Long-term Plan. ... We wait to see if it will mean a growth in CCG and ICS
More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Merck & Co's cancer drug Keytruda gaining traction in US
- Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
